natgillin/translations-raw huggingface dataset:
If you have an injection site reaction (redness, rash, or itching) you may like to ask your doctor for something to help relieve any signs or symptoms. 
Če se pojavi reakcija na mestu injiciranja (rdečina, izpuščaj ali srbečica), lahko zdravnika prosite za zdravilo, ki bo pomagalo ublažiti znake in simptome.
If you still cannot push the button in, this may mean that the needle is clogged. 
Če gumba še vedno ne morete potisniti noter, to lahko pomeni, da je igla zamašena.
Name and address of the manufacturers responsible for batch release AstraZeneca AB 
Ime in naslov izdelovalcev, odgovornih za sproščanje serij AstraZeneca AB
Do not try to unlock with excessive force or tools. 
Peresnika ne poskušajte odkleniti s prekomerno silo ali z orodji.
C. Check the mix. 
C. Preverite mešanico.
The absolute change in 2-hour postprandial plasma glucose at Week 28 is modeled similarly using ANCOVA. 
Absolutna sprememba postprandialne koncentracije glukoze v plazmi 2 uri po obroku po 28 tednih je modelirana podobno z uporabo ANCOVA.
Not known (frequency cannot be estimated from the available data) In addition some other side effects have been reported 
Neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti) Poleg tega so poročali o nekaterih drugih neželenih učinkih:
Clean the area with an alcohol swab. 
Očistite predel z alkoholnim zložencem.
Gently clean the area with soap and water or an alcohol swab. 
Predel previdno očistite z milom in vodo ali z alkoholnim zložencem.
You can also change your chosen injection day, as long as your last dose was given 3 or more days before. 
Dan za injekcijo lahko tudi spremenite pod pogojem, da ste zadnji odmerek uporabili pred 3 dnevi ali več.
Make a note that you have taken your Bydureon today and mark your calendar for when you are due for your next injection. 
Označite si, da ste danes že vzeli zdravilo Bydureon in na koledarju označite, kdaj je vaša naslednja injekcija.
The pen contains an integrated needle. 
Peresnik ima integrirano iglo.
Frequencies reported in pooled data from the controlled periods of the two phase 3 clinical studies (n = 410). 
Pogostnosti, poročane v združenih podatkih iz kontroliranih obdobij dveh kliničnih študij 3. faze (n = 410).
No predetermined dose adjustment is required; however, lipid profiles should be monitored as appropriate. 
Vnaprejšnja prilagoditev odmerkov ni potrebna, zato pa je potrebno ustrezno nadzorovati lipidni profil.
Figure 1: Time to First Adjudicated MACE (intent to treat patients) 
Slika 1: Čas do prvega presojenega dogodka MACE (bolniki z-namenom-zdravljenja)
These clumps could clog the needle when you take the injection (see question 7). 
Te grudice lahko med injiciranjem zamašijo iglo (glejte 7. vprašanje).
1a Take a single-dose kit from the refrigerator. 
1a Enoodmerni set vzemite iz hladilnika.
Patients with an Event (%) 
Bolniki z dogodkom (%)
Prolonged-release exenatide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. 
Eksenatida v obliki s podaljšanim sproščanjem ne smemo uporabljati pri bolnikih z diabetesom mellitusom tipa 1 ali za zdravljenje diabetične ketoacidoze.
You do not see it before, during, or after using the pen. 
Ne boste je videli niti pred uporabo peresnika, niti med uporabo ali po uporabi.
NOT Mixed Well 
Ni dobro premešano
Detailed information on this medicine is available on the website of the European Medicines Agency http://www.ema.europa.eu/ 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu/
Prolonged-release exenatide can be administered at any time of day, with or without meals. 
Eksenatid v obliki s podaljšanim sproščanjem se lahko uporabi kadarkoli tekom dneva, s hrano ali brez nje.
If you feel you should stop using this medicine, please consult your doctor first. 
Če menite, da bi morali prenehati uporabljati to zdravilo, se o tem najprej posvetujte z zdravnikom.
Do not recycle the container with used pens. 
Vsebnika z uporabljenimi peresniki ne reciklirajte.
Prolonged-release exenatide has minor influence on the ability to drive and use machines. 
Eksenatid v obliki s podaljšanim sproščanjem ima blag vpliv na sposobnost vožnje in upravljanja strojev.
Figure 2: Forest Plot: Analysis of Primary and Secondary Endpoints (intent to treat patients) 
Slika 2: Drevesni diagram: Analiza primarnih in sekundarnih opazovanih dogodkov (bolniki z-namenom-zdravljenja)
Nonclinical studies have shown that exenatide is predominantly eliminated by glomerular filtration with subsequent proteolytic degradation. 
Predklinične študije so pokazale, da se eksenatid izloča pretežno z glomerulno filtracijo z nadaljnjo proteolitično razgradnjo.
To prevent losing medicine, do not push in the plunger while attaching the needle. 
Da preprečite izgubo zdravila, med pritrjevanjem igle ne pritiskajte na bat.
The effect on HbA1c remained clinically significant over 52 weeks but partially diminished over time in the group that had initially received Bydureon BCise. 
Vpliv na HbA1c je ostal klinično pomemben do 52. tedna, a se je sčasoma delno zmanjšal v skupini, ki je uvodoma prejemala zdravilo Bydureon BCise.
You can re-mix your medicine if your pen is in the locked position. 
Zdravilo lahko znova premešate, če je peresnik v zaklenjenem položaju.
DO NOT push the injection button yet. 
Gumba za injiciranje še NE PRITISNITE.
After the suspension is fully mixed, the preparation steps must be completed immediately and the suspension injected subcutaneously. 
Ko je suspenzija popolnoma premešana, je treba korake za pripravo opraviti nemudoma in suspenzijo injicirati subkutano.
Do not use Bydureon: - If you are allergic to exenatide or any of the other ingredients of this medicine (listed in section 
Ne uporabljajte zdravila Bydureon - Če ste alergični na eksenatid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Also be sure you twisted the knob until it stopped, the orange label disappeared, and the injection button appears. 
Prav tako se prepričajte, da ste zasukali gumb, dokler se ne ustavi, oranžna nalepka izgine in se pojavi gumb za injiciranje.
Exenatide Placebo 
eksenatid placebo
2 Connecting the parts 3 Mixing the medicine and filling the syringe 4 Injecting the medicine 
2 Povezovanje sestavnih delov 3 Mešanje zdravila in polnjenje injekcijske brizge 4 Injiciranje zdravila
This is what the broken-off cap looks like. 
Tako izgleda odlomljen pokrovček.
Tap the vial several times against a hard surface to loosen the powder. 
Z vialo nekajkrat potrkajte ob trdno površino, da razrahljate prašek.
Paediatric population Interaction studies with exenatide have only been performed in adults. 
Pediatrična populacija Študije medsebojnega delovanja z eksenatidom so izvedli le pri odraslih.
What if the device malfunctions and I cannot remove the orange cap? 
Kaj, če pripomoček ne deluje pravilno in ne morem odstraniti oranžnega pokrovčka?
It is an injectable medicine used to improve blood sugar control in adults with type 2 diabetes mellitus. 
To je zdravilo za injiciranje, ki ga uporabljamo za izboljšanje nadzora sladkorja v krvi pri odraslih s sladkorno boleznijo tipa 2.
Keep shaking until the liquid and powder are mixed well. 
S stresanjem nadaljujte, dokler nista tekočina in prašek dobro zmešana.
What Bydureon is and what it is used for 
Kaj je zdravilo Bydureon in za kaj ga uporabljamo
Examination of antibody-positive specimens revealed no significant cross-reactivity with similar endogenous peptides (glucagon or GLP-1). 
Preiskava vzorcev s pozitivnimi protitelesi ni pokazala značilne navzkrižne reaktivnosti s podobnimi endogenimi peptidi (glukagon ali GLP-1).
Then, take your thumb off the plunger. 
Nato palec odstranite iz bata.
Using too much of this medicine can cause nausea, vomiting, dizziness, or symptoms of low blood sugar (see section 4). 
Če uporabite preveč tega zdravila, to lahko povzroči slabost (siljenje na bruhanje), bruhanje, omotico ali simptome nizkega krvnega sladkorja (glejte poglavje 4).
The mean HbA1c was 8.1%. 
Povprečni HbA1c je bil 8,1 %.
The day of weekly administration can be changed if necessary as long as the last dose was administered at least three days before. 
Dan tedenske uporabe se po potrebi lahko zamenja, pri čemer pa mora biti zadnji odmerek uporabljen vsaj tri dni prej.
- If you have type 1 diabetes or diabetic ketoacidosis, as this medicine should not be used. 
- Če imate sladkorno bolezen tipa 1 ali diabetično ketoacidozo, ker v tem primeru tega zdravila ne smete uporabljati.
The patient does not need to save any part of the single-use kit. 
Bolniku ni treba prihraniti nobenega dela seta za enkratno uporabo.
The medicine is mixed well when the liquid looks cloudy from both sides of the window. 
Zdravilo je dobro premešano, ko je tekočina motna na obeh straneh okenca.
After I mix the medicine, how long can I wait before taking the injection? 
Koliko časa lahko po premešanju zdravila počakam, preden dam injekcijo?
There is little experience with this medicine in patients with kidney problems. 
S tem zdravilom je malo izkušenj pri bolnikih, ki imajo težave z ledvicami.
Digoxin and lisinopril 
Digoksin in liziniopril
Your doctor is now prescribing this medicine as an additional medicine to help control your blood sugar. 
Zdravnik vam je predpisal to zdravilo kot dodatno zdravilo, ki vam bo pomagalo nadzorovati vrednosti vašega sladkorja v krvi.
• Store in packaging provided to protect from light until you are ready to prepare and use your dose. 
• Zdravilo shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo, dokler niste pripravljeni za pripravo in injiciranje odmerka.
Unlike native GLP-1, prolongedrelease exenatide has a pharmacokinetic and pharmacodynamic profile in humans suitable for once weekly administration. 
V nasprotju z nativnim GLP-1 ima eksenatid v obliki s podaljšanim sproščanjem tak farmakokinetični in farmakodinamični profil pri ljudeh, da je primeren za uporabo enkrat tedensko.
Ask your pharmacist how to safely throw away the container with used pens and needles. 
Farmacevta vprašajte, kako varno zavreči vsebnik z uporabljenimi peresniki in iglami.
Prolonged-release exenatide that has been frozen must not be used. 
Eksenatida v obliki s podaljšanim sproščanjem, ki je bil zamrznjen, ne smete uporabiti.
• Continue holding the pen upright to prevent the medicine from accidently leaking. 
• Še naprej držite peresnik pokonci, da boste preprečili naključno iztekanje zdravila.
See Description of selected adverse reactions section, below. 
Glejte Opis izbranih neželenih učinkov, spodaj.
1 Getting started 
1 Začetek
One patient was reported with major hypoglycaemia since he had a low blood glucose value (2.2 mmol/l) and requested assistance with oral carbohydrate treatment which resolved the event. 
Pri enem bolniku so poročali o hujši hipoglikemiji, saj je bila pri njem vrednost glukoze v krvi nizka (2,2 mmol/l) in je potreboval pomoč peroralnih ogljikovih hidratov, kar je rešilo stanje.
Keep this flap open so you can refer to it as you go through the steps 
Zaščito pustite odprto, da boste lahko sledili, ko greste skozi opisane korake
Pharmacotherapeutic group: Drugs used in diabetes, glucagon-like peptide-1 (GLP-1) analogues, ATC code: A10BJ01. 
Farmakoterapevtska skupina: Zdravila za zdravljenje diabetesa, analogi glukagonu podobnega peptida-1 (GLP-1), oznaka ATC: A10BJ01.
Press the top of the vial firmly into the orange connector. 
Vrh viale močno pritisnite v oranžni povezovalec.
Bydureon BCise pen can be kept at room temperature for up to 4 weeks. 
Peresnik Bydureon BCise je mogoče hraniti na sobni temperaturi do 4 tedne.
The mean dose of insulin glargine at the beginning of treatment was 10.1 IU/day rising to 31.1 IU/day for insulin glargine-treated patients. 
Srednja vrednost odmerka insulina glargina na začetku zdravljenja je bila 10,1 i.e./dan in je narasla na 31,1 i.e./dan pri bolnikih, zdravljenih z insulinom glarginom.
Air bubbles are not a problem with this type of injection. 
Zračni mehurčki pri takšni vrsti injiciranja niso problem.
− Needle is hidden. 
− Igla je skrita.
You may use a biohazard container, another hard plastic container, or a metal container. 
Uporabite lahko vsebnik za biološko nevarne odpadke, kakšen drug vsebnik iz trde plastike ali kovinski vsebnik.
Shake vigorously like you would shake a bottle of oil-and-vinegar salad dressing. 
Močno stresajte, kot bi stresali steklenico s solatnim prelivom iz olja in kisa.
You should not use this medicine while breast-feeding. 
Tega zdravila med dojenjem ne smete uporabljati.
Subsequent injections should use a different site of injection each week. 
Mesto injiciranja nadaljnjih injekcij naj bo vsak teden različno.
During these next steps, you will be mixing the medicine and filling the syringe. 
V naslednjih korakih boste mešali zdravilo in polnili injekcijsko brizgo.
Overall, the level of glycaemic control (HbA1c) in patients treated with Bydureon BCise with low titre antibodies at the last visit (-1.1% to -1.5%) was comparable to that observed in those without antibody titres (-1.1% to -1.4%). 
Na splošno je bila raven urejenosti glikemije (HbA1c) pri bolnikih, ki so bili zdravljeni z zdravilom Bydureon BCise in so imeli ob zadnjem obisku nizke titre protiteles (-1,1 % do -1,5 %), primerljiva s tisto, opaženo pri bolnikih, ki niso imeli titrov protiteles (-1,1 % do -1,4 %).
Do not touch the orange connector inside. 
Notranjega oranžnega povezovalca se ne dotikajte.
The pooled clinical studies data set for Bydureon BCise comprises two phase 3 comparator-controlled studies of 6 to 12 months duration. 
Združeni podatki kliničnih študij za zdravilo Bydureon BCise obsegajo podatke dveh od 6- do 12-mesečnih kontroliranih študij 3. faze s primerjalno učinkovino.
B. Make sure you received your full dose. 
B. Preverite, ali ste prejeli celotni odmerek.
Use a new pen for each injection. 
Za vsako injiciranje uporabite nov peresnik.
D. Compare both sides of the mixing window to the photos below, 
D. Primerjajte obe strani okenca za mešanje s spodnjimi fotografijami tako, da podržite peresnik ob strani.
If you lose weight too quickly (more than 1.5 kg per week) talk to your doctor about it since this may cause problems such as gallstones. 
Če telesno maso izgubite prehitro (več kot 1,5 kg na teden), se o tem pogovorite z zdravnikom, ker to lahko povzroči težave, kot npr. žolčne kamne.
Subsequently, exenatide concentrations of approximately 153-208 pg/ml were maintained, indicating that steady state was achieved. 
Po tem je koncentracija eksenatida ostala na približno 153-208 pg/ml, kar je znak, da je bilo doseženo stanje dinamičnega ravnovesja.
Bydureon BCise pen should be stored as follows: 
Peresnik Bydureon BCise je treba shranjevati kot sledi:
The solvent should be visually inspected prior to use. 
Vehikel je pred uporabo potrebno dobro vizualno pregledati.
Animal studies with exenatide did not indicate harmful effects with respect to fertility; high doses of exenatide caused skeletal effects and reduced foetal and neonatal growth. 
Študije na živalih z eksenatidom niso pokazale neposrednih škodljivih učinkov na plodnost; veliki odmerki eksenatida so povzročili učinke na okostju in manjšo rast ploda in novorojenčka.
You will need a puncture-resistant container that is large enough to hold the entire pen. 
Potrebovali boste vsebnik, odporen proti prebadanju, ki je dovolj velik, da drži celoten peresnik.
It will be easier to mix the medicine if the pen is at room temperature. 
Zdravilo boste lažje premešali, če bo peresnik ogret na sobno temperaturo.
This medicine is provided as a powder and solvent (liquid) for suspension for injection in a pre-filled pen. 
To zdravilo je na voljo kot prašek in vehikel (tekočina) za suspenzijo za injiciranje v napolnjenem injekcijskem peresniku.
You cannot save it for later use. 
Ne morete ga shraniti za poznejšo uporabo.
- If you have severe problems with your stomach emptying (including gastroparesis) or food digestion, as the use of this medicine is not recommended. 
- Če imate hude težave s praznjenjem želodca (vključno z gastroparezo) ali prebavo hrane, ker uporaba tega zdravila v tem primeru ni priporočljiva.
After the click, continue to hold the needle in your skin for 10 seconds. 
Po kliku naj ostane igla v koži še 10 sekund.
The vital status was known at the end of the study for 98.9% and 98.8% of the patients in the prolonged-release exenatide and placebo group, respectively. 
Vitalno stanje je bilo ob koncu študije znano za 98,9 % bolnikov v skupini z eksenatidom v obliki s podaljšanim sproščanjem in za 98,8 % bolnikov v skupini s placebom.
Hold the vial connector package. 
Držite paket s povezovalcem viale.
• nausea (nausea is most common when starting this medicine, but decreases over time in most patients) 
• slabost (slabost je najpogostejša na začetku zdravljenja s tem zdravilom, vendar se pri večini bolnikov sčasoma zmanjša)
Weight loss was sustained over 7 years in these patients. 
Pri teh bolnikih je bila izguba telesne mase v 7 letih vzdrževana.
On average in the phase 3 studies, 12% of the patients had higher titre antibodies. 
V študijah III. faze je imelo povprečno 12 % bolnikov visok titer protiteles.
Subsequently, exenatide concentrations of approximately 151-265 pg/ml were maintained indicating that steady state was achieved. 
Po tem je koncentracija eksenatida ostala na približno 151-265 pg/ml, kar je znak, da je bilo doseženo stanje dinamičnega ravnovesja.
How soon to inject after mixing Mixing the medicine 
Kako hitro po mešanju injicirati Mešanje zdravila
In addition, a double-blind, placebo-controlled cardiovascular outcome study (EXSCEL) enrolled 14,752 subjects with type 2 diabetes and any level of CV risk when added to the current usual care. 
Poleg tega je dvojno slepa, s placebom kontrolirana študija srčno-žilnih izidov (EXSCEL) zajela 14.752 bolnikov s sladkorno boleznijo tipa 2 in kakršno koli ravnjo srčno-žilnega tveganja, po dodatku k trenutnemu običajnemu zdravljenju.
This will help you get the correct dose of medicine. 
To vam bo pomagalo vzeti pravilen odmerek zdravila.
Prolonged-release exenatide should be administered once a week on the same day each week. 
Eksenatid v obliki s podaljšanim sproščanjem se daje enkrat tedensko, na enak dan v tednu.
If you are not sure you have taken the full dose of Bydureon If you are not sure if you have taken all of your dose, do not inject another dose of this medicine, just take it next week as planned. 
Če niste prepričani, ali ste vzeli celotni odmerek zdravila Bydureon Če niste prepričani, ali ste vzeli celotni odmerek, si ne injicirajte še enega.
The use of this medicinal product does not require additional self-monitoring. 
Uporaba tega zdravila ne zahteva dodatnega bolnikovega samonadzora.
It may help to hold the pen up to the light to see in the window. 
Pomaga lahko, če peresnik podržite proti svetlobi, da boste videli okence.
After you lift the pen from your skin, the green shield will move back up to lock over the needle. 
Ko boste peresnik dvignili s kože, se bo zeleni ščitnik pomaknil nazaj navzgor in se bo zaskočil nad iglo.
In a proportion of these the glycaemic response to prolonged-release exenatide was absent at the end of the controlled period of studies; 2.6% of patients showed no glucose improvement with higher titre antibodies whereas 1.6% showed no improvement while antibody negative. 
Pri deležu je bil glikemični odziv na eksenatid v obliki s podaljšanim sproščanjem ob koncu kontroliranih študij odsoten; 2,6 % bolnikov ni pokazalo izboljšanja glukoze z višjimi titri protiteles, 1,6 % bolnikov pa ni pokazalo izboljšanja, ko so bili negativni za protitelesa.
The primary safety (noninferiority) and efficacy (superiority) endpoint in EXSCEL was the time to first confirmed Major Adverse Cardiac Event (MACE): cardiovascular (CV)-related death, nonfatal myocardial infarction (MI) or nonfatal stroke. 
Primarni opazovani dogodek varnosti (neinferiornost) in učinkovitosti (superiornost) v študiji EXSCEL je bil čas do prvega potrjenega hudega srčnega neželenega dogodka (MACE - Major Adverse Cardiac Event): smrti zaradi SŽ vzroka, miokardnega infarkta (MI) brez smrtnega izida ali možganske kapi brez smrtnega izida.
Connecting the parts 
Povezovanje sestavnih delov
- If you lose weight too quickly (more than 1.5kg per week)talk to your doctor about it since this may cause problems such as gallstones. 
- Če telesno maso izgubljate prehitro (več kot 1,5 kg na teden), se o tem pogovorite z zdravnikom, ker vam to lahko povzroči težave, kot npr. žolčne kamne.
Interaction with warfarin 
Medsebojno delovanje z varfarinom
All patients with missing endpoint data are imputed as non-responders. 
Vsi bolniki, ki niso imeli podatkov o opazovanem dogodku, so bili obravnavani kot neodzivni.
Do not go to the next step unless your medicine is mixed well. 
Ne nadaljujte z naslednjim korakom, dokler zdravilo ni dobro premešano.
• skin reactions at the injection site following injection of exenatide. 
• kožne reakcije na mestu injiciranja po injekciji eksenatida.
Fertility No fertility studies in humans have been conducted. 
Plodnost Študij plodnosti pri ljudeh niso izvedli.
While patients with high titre antibodies at the last visit had an attenuated HbA1c response, HbA1c reductions in these patients were clinically relevant (-0.6% to -0.7%). 
Bolniki z visokimi titri protiteles na zadnjem obisku so imeli sicer manjši odziv HbA1c, vendar so bila znižanja HbA1c pri teh bolnikih klinično pomembna (-0,6 % do -0,7 %).
• has a lid, 
• ima pokrov,
The reduction in Cmax is of limited clinical relevance and no adjustment of dosing of oral contraceptives is required. 
Znižanje Cmax ima majhno klinično pomembnost, zato prilagoditev odmerjanja peroralnih kontraceptivov ni potrebna.
Also read the Package Leaflet in your carton. 
Preberite tudi Navodilo za uporabo, ki se nahaja v vaši škatli.
There are no adequate data from the use of prolonged-release exenatide in pregnant women. 
O uporabi eksenatida v obliki s podaljšanim sproščanjem pri nosečih ženskah nimamo ustreznih podatkov.
C. Check the liquid, inside the inspection window. 
C. Preverite tekočino skozi okence za ogled.
A. Let your pen warm up. 
A. Pustite, da se peresnik ogreje.
• Do not use past the expiration date. 
• Ne uporabljajte po datumu izteka roka uporabnosti.
Effects of overdoses with exenatide (based on immediate-release exenatide clinical studies) included severe nausea, severe vomiting and rapidly declining blood glucose concentrations. 
Učinki prevelikega odmerjanja eksenatida (na osnovi kliničnih študij z eksenatidom v obliki s takojšnim sproščanjem) so vključevali hudo navzeo, hudo bruhanje in hitro padanje koncentracije glukoze v krvi.
D. Inject the medicine. 
D. Injicirajte zdravilo.
Very common side effects (may affect more than 1 in 10 people) • hypoglycaemia (low blood sugar) when taken with a medicine that contains a sulphonylurea 
Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov) • hipoglikemija (nizek krvni sladkor) v primeru uporabe z zdravilom, ki vsebuje sulfonilsečnino.
When you unscrew the orange cap, the green shield keeps the needle covered until you inject. 
Ko odvijete oranžni pokrovček, zeleni ščitnik prekriva iglo, dokler ne injicirate zdravila.
The mean apparent volume of distribution of exenatide following subcutaneous administration of a single dose of exenatide is 28 l. 
Povprečni navidezni volumen porazdelitve eksenatida po subkutanem dajanju enkratnega odmerka eksenatida je 28 l.
Why should I inject my medicine right away after mixing it? 
Zakaj moram zdravilo injicirati takoj potem, ko ga premešam?
The air bubbles will not harm you or affect your dose. 
Zračni mehurčki vam ne bodo škodovali ali vplivali na vaš odmerek.
If you see any clumps, keep tapping. 
Če vidite grudice, trkajte naprej.
Be careful not to push in the plunger. 
Pazite, da ne pritisnete na bat.
Put the covered needle down. 
Odložite pokrito iglo.
This is what the syringe should now look like. 
Tako mora sedaj izgledati injekcijska brizga.